Loading chat...
MA H4490
Bill
Status
Introduced
9/18/2025
Primary Sponsor
Joint Committee on Financial Services
Click for details
AI Summary
- Prohibits insurers and drug coverage plans from reimbursing 340B-covered entities or contract pharmacies at lower rates than non-340B pharmacies for the same drugs
- Bans discriminatory practices against 340B participants including differential fees, chargebacks, clawbacks, dispensing fees, pharmacy network restrictions, and audit requirements
- Prohibits requiring claims to identify drugs as 340B unless the claim is for Medicaid payment
- Bars drug manufacturers and distributors from restricting 340B drug acquisition or delivery to contract pharmacies, or requiring data submissions as a condition of drug access
- Protects patient choice by prohibiting insurers from steering patients away from receiving drugs at 340B-covered entities or their contract pharmacies
- Violations by manufacturers/distributors constitute unfair or deceptive practices under Chapter 93A, with enforcement authority granted to the Attorney General and Board of Registration in Pharmacy
Legislative Description
Prohibiting discrimination against 340b drug discount program participants
Last Action
Reported favorably by committee and referred to the Joint Committee on Health Care Financing
9/18/2025
Committee Referrals
Health Care Financing9/18/2025
Full Bill Text
No bill text available